MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, ARCT made $17,151,000 in revenue. -$13,448,000 in net income. Net profit margin of -78.41%.

Income Overview

Revenue
$17,151,000
Net Income
-$13,448,000
Net Profit Margin
-78.41%
EPS
-$0.49
Unit: Dollar
Revenue Breakdown
    • Csl Seqirus
    • Biomedical Advanced Research And...
    • Gates Foundation
    • Other
Revenue Breakdown
    • Csl Seqirus
    • Biomedical Advanced Research And...
    • Gates Foundation
    • Other

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenue
17,151,000 28,301,000 29,382,000 36,879,000
Research and development, net
23,265,000 29,579,000 34,893,000 52,007,333.333
General and administrative
10,398,000 10,338,000 11,315,000 13,182,333.333
Total operating expenses
33,663,000 39,917,000 46,208,000 65,189,666.667
Loss from operations
-16,512,000 -11,616,000 -16,826,000 -28,310,666.667
Loss from foreign currency
-170,000 -127,000 -21,000 -90,000
Finance income, net
3,234,000 2,567,000 2,771,000 3,792,333.333
Net loss before income taxes
-13,448,000 -9,176,000 -14,076,000 -24,608,333.333
Provision (benefit) for income taxes
-4,000 -71,000
Net loss
-13,448,000 -9,180,000 -14,076,000 -24,679,333.333
Comprehensive loss
-13,448,000 -9,180,000 -14,076,000 -24,679,333.333
Basic
-0.49 -0.34 -0.52 -0.913
Basic
27,188,000 27,129,000 27,107,000 -20,666.667
Diluted
-0.49 -0.34 -0.52 -0.913
Diluted
27,188,000 27,129,000 27,107,000 -20,666.667
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$13,448,000 Net loss-$13,448,000 Gates Foundation$1,103,000 Biomedical AdvancedResearch And Development...$1,895,000 Other$600,000 Csl Seqirus$13,553,000 Net loss beforeincome taxes-$13,448,000 Finance income, net$3,234,000 Grant$2,998,000 Collaboration Revenue$14,153,000 Loss from foreigncurrency-$170,000 Loss from operations-$16,512,000 Total revenue$17,151,000 Total operatingexpenses$33,663,000 General andadministrative$10,398,000 Research anddevelopment, net$23,265,000

Arcturus Therapeutics Holdings Inc. (ARCT)

Arcturus Therapeutics Holdings Inc. (ARCT)